Bank of America’s PharmaCyte Biotech PMCB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $591 | Buy |
542
+469
| +642% | +$511 | ﹤0.01% | 6595 |
|
|
2025
Q1 | $92 | Sell |
73
-5
| -6% | -$6 | ﹤0.01% | 6792 |
|
|
2024
Q4 | $123 | Sell |
78
-39
| -33% | -$61 | ﹤0.01% | 6767 |
|
|
2024
Q3 | $223 | Sell |
117
-35
| -23% | -$67 | ﹤0.01% | 6609 |
|
|
2024
Q2 | $298 | Buy |
152
+98
| +181% | +$192 | ﹤0.01% | 6572 |
|
|
2024
Q1 | $128 | Sell |
54
-8
| -13% | -$19 | ﹤0.01% | 6477 |
|
|
2023
Q4 | $135 | Sell |
62
-54
| -47% | -$118 | ﹤0.01% | 6416 |
|
|
2023
Q3 | $243 | Buy |
116
+62
| +115% | +$130 | ﹤0.01% | 6459 |
|
|
2023
Q2 | $154 | Hold |
54
| – | – | ﹤0.01% | 6502 |
|
|
2023
Q1 | $157 | Sell |
54
-44
| -45% | -$128 | ﹤0.01% | 6612 |
|
|
2022
Q4 | $286 | Buy |
98
+44
| +81% | +$128 | ﹤0.01% | 6666 |
|
|
2022
Q3 | $0 | Sell |
54
-1,680
| -97% | – | ﹤0.01% | 7111 |
|
|
2022
Q2 | $4K | Buy |
1,734
+1,676
| +2,890% | +$3.87K | ﹤0.01% | 6815 |
|
|
2022
Q1 | $0 | Hold |
58
| – | – | ﹤0.01% | 7640 |
|
|
2021
Q4 | $0 | Hold |
58
| – | – | ﹤0.01% | 7531 |
|
|
2021
Q3 | $0 | Buy |
+58
| New | – | ﹤0.01% | 7314 |
|